PCI BIOTECH AS has a total of 180 patent applications. It decreased the IP activity by 36.0%. Its first patent ever was published in 2000. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ONYVAX LTD, CLIO INC and NOVARX.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 36 | |
#2 | EPO (European Patent Office) | 18 | |
#3 | WIPO (World Intellectual Property Organization) | 17 | |
#4 | Canada | 16 | |
#5 | United States | 14 | |
#6 | Australia | 13 | |
#7 | China | 12 | |
#8 | Brazil | 10 | |
#9 | Republic of Korea | 10 | |
#10 | Hong Kong | 5 | |
#11 | New Zealand | 5 | |
#12 | Hungary | 4 | |
#13 | Mexico | 3 | |
#14 | Poland | 3 | |
#15 | Singapore | 3 | |
#16 | Czechia | 2 | |
#17 | Japan | 2 | |
#18 | Norway | 2 | |
#19 | South Africa | 2 | |
#20 | India | 1 | |
#21 | Serbia | 1 | |
#22 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Micro-structure and nano-technology | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Electrotherapy | |
#5 | Polysaccharides | |
#6 | Peptides | |
#7 | Unspecified technologies | |
#8 | Nanostructure applications | |
#9 | Syringes | |
#10 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Hogset Anders | 58 |
#2 | Berg Kristian | 47 |
#3 | Høgset Anders | 40 |
#4 | Prasmickaite Lina | 21 |
#5 | Selbo Pal Kristian | 19 |
#6 | Klaveness Jo | 16 |
#7 | Eivindvik Kristin | 14 |
#8 | Walday Per Edvard | 14 |
#9 | Gaware Vivek S | 12 |
#10 | Johansen Pal | 12 |
Publication | Filing date | Title |
---|---|---|
GB202103443D0 | Method | |
GB202101726D0 | Method | |
GB202003594D0 | Method | |
GB201903491D0 | Method | |
GB201804276D0 | Method | |
GB201801169D0 | Method | |
GB201718631D0 | Method | |
WO2018069536A1 | Treatment of cholangiocarcinoma with tpcs-2a induced photochemical internalisation of gemcitabine | |
GB201704719D0 | Method | |
GB201704288D0 | Method | |
GB201617526D0 | Method | |
GB201604572D0 | Method | |
US2017252441A1 | Compound and method | |
GB201504605D0 | Method | |
GB201503776D0 | Compound and method | |
GB201420773D0 | Compound and method | |
EP3129045A1 | Method of treating melanoma | |
GB201415247D0 | Compound and method | |
WO2015028575A1 | Immunisation method by photochemical internalisation | |
GB201415250D0 | Compound and method |